Hyderabad: Hyderabad-based MSN Laboratories became the first company to launch the generic Canreal injection (Cangrelor) in India, indicated as an adjunct to percutaneous coronary intervention (PCI), also known as coronary angioplasty, a nonsurgical procedure that improves blood flow to heart. The drug reduces the risk of periprocedural myocardial infarction (MI), repeat coronary revascularisation, and stent […]
